Hepatocyte-based applications, such as metabolism/hepatotoxicity testing of drug like candidates in drug discovery, require optimal in vitro culture model for hepatocyte functional maintenance. Despite of the rapid emerging of novel hepatocyte 3D culture model with high fidelity of in vivo mimicry, Big Pharmas currently still prefer simple 2D culture model (i.e. 2D hepatocyte monolayer on natural extracellular matrix-coated microplate) and neglect the complex 3D culture models due to their difficulties to be adapted to the automated high-throughput screening platform. Conventional cell...